prof. Michał Panek (Łódź, Poland)

organised within the framework of the research and training grant awarded by GSK

prof. Piotr Boros (Warszawa, Poland)

organised within the framework of the research and training grant awarded by Celon Pharma

organised within the framework of the research and training grant awarded by PTA

prof. Marek Niedoszytko (Gdańsk, Poland)

1. Mastocytosis – latest reports
   prof. Marek Niedoszytko (Gdańsk, Poland)
   9:00 AM - 9:20 AM
2. Post-infectious (including post-COVID) bronchial hyperresponsiveness: mechanisms, best therapeutic options
   dr Izabela Kupryś-Lipińska (Łódź, Poland)
   9:20 AM - 9:40 AM
3. Is pollen allergy in its decline?
   dr Piotr Rapiejko (Warszawa, Poland)
   9:40 AM - 10:00 AM
4. Metal implants – a challenge for allergists
   prof. Alicja Grzanka (Katowice, Poland)
   10:00 AM - 10:20 AM
5. Discussion
   
   10:20 AM - 10:30 AM

organised within the framework of the research and training grant awarded by PTA

prof. Jerzy Kruszewski (Warszawa, Poland)

1. Introduction
   prof. Jerzy Kruszewski (Warszawa, Poland)
   10:30 AM - 10:35 AM
2. Currently available vaccines against COVID-19
   prof. Andrzej Chciałowski (Warszawa, Poland)
   10:35 AM - 10:50 AM
3. The Basophil Activation Test (BAT) in the diagnostics of hypersensitivity to polyethylene glycol
   dr Magdalena Zbikowska-Götz (Bydgoszcz, Poland)
   10:50 AM - 11:05 AM
4. SPT in the diagnostics of hypersensitivity to COVID-19 vaccines
   prof. Marek Niedoszytko (Gdańsk, Poland)
   11:05 AM - 11:20 AM
5. Discussion
   
   11:20 AM - 11:30 AM

organised within the framework of the research and training grant awarded by PTA

prof. Roman J. Nowicki (Gdańsk, Poland)

1. Whether and when to perform allergy testing in patients with atopic dermatitis?
   prof. Radosław Śpiewak (Kraków, Poland)
   10:30 AM - 10:55 AM
2. AD: an interdisciplinary medical problem?
   prof. Roman J. Nowicki (Gdańsk, Poland)
   10:55 AM - 11:20 AM
3. Personalised therapy in AD
   prof. Magdalena Trzeciak (Gdańsk, Poland)
   11:20 AM - 11:45 AM
4. Discussion
   
   11:45 AM - 12:00 PM

organised within the framework of the research and training grant awarded by PTA

dr Ewa Bogacka (Wrocław, Poland), prof. Magdalena Czarnecka-Operacz (Poznań, Poland)

organised within the framework of the research and training grant awarded by PTA

Experts:
dr Ewa Bogacka (bronchial asthma)
prof. Magdalena Czarnecka-Operacz (AD and other dermatoses)

prof. Piotr Kuna (Łódź, Poland)

1. GINA 2021. Are there any new developments?
   prof. Maciej Kupczyk (Łódź, Poland)
   12:30 PM - 12:45 PM
2. New IND/MF and IND/GLY/MF combinations: do they mark an advance in inhaled asthma therapy?
   prof. Paweł Śliwiński (Warszawa, Poland)
   12:45 PM - 1:00 PM
3. Summary of 2021 – advances in asthma therapy
   prof. Piotr Kuna (Łódź, Poland)
   1:00 PM - 1:05 PM
4. Why combination drugs can improve compliance and reduce polypragmasy
   dr hab. Jarosław Woroń (Kraków, Poland)
   1:05 PM - 1:20 PM
5. Q&A
   
   1:20 PM - 1:30 PM

prof. Jerzy Kruszewski (Warszawa, Poland), prof. Krzysztof Buczyłko (Łódź, Poland)

1. Prof. Marek L. Kowalski in our memory
   prof. Maciej Chałubiński (Łódź, Poland)
   12:30 PM - 12:50 PM
2. Discovering the essence of allergy
   prof. Krzysztof Buczyłko (Łódź, Poland), prof. Jerzy Kruszewski (Warszawa, Poland)
   12:50 PM - 1:10 PM
3. Anti-vaccination movements in the history of fight against infectious diseases
   prof. Jerzy Kruszewski (Warszawa, Poland), prof. Krzysztof Buczyłko (Łódź, Poland)
   1:10 PM - 1:30 PM
4. Profile of an outstanding allergist, Prof. Bogdan Romański
   prof. Zbigniew Bartuzi (Bydgoszcz, Poland)
   1:30 PM - 1:50 PM
5. Discussion
   
   1:50 PM - 2:00 PM

organised within the framework of the research and training grant awarded by PTA

1. The leading role of SMART therapy in the latest GINA guidelines
   prof. Maciej Kupczyk (Łódź, Poland)
   1:30 PM - 2:00 PM
2. Spiromax – the “green” inhaler: the role of carbon footprint
   prof. Andrzej Emeryk (Lublin, Poland)
   2:00 PM - 2:15 PM

organised within the framework of the research and training grant awarded by Teva

prof. Roman J. Nowicki (Gdańsk, Poland), dr Maria Mozga (Łódź, Poland)

1. Quality of life in chronic urticaria – analysis of patients from the Department of Dermatology, Poznan University of Medical Sciences
   
   2:00 PM - 2:12 PM

   A. Błaszczyk, D. Jenerowicz, F. Raciborski, A. Sadowska-Przytocka, Z. Adamski, M. Czarnecka-Operacz
   
   Institute of Allergic and Occupational Skin Diseases, Poznan University of Medical Sciences, Poland

2. Evaluation of cytokine profile in patients with coexisting atopic dermatitis and psoriasis
   
   2:12 PM - 2:24 PM

   M. Drewienkowska, K. Dryjka, A. Mędrala, A. Bogacz, A. Bożek
   
   Department and Clinic Department of Internal Diseases, Dermatology and Allergology in Zabrze, Medical University of Silesia in Katowice, Poland

3. Acquired angioedema with C1-inhibitor deficiency responding to glucocorticosteroid treatment – case report
   
   2:24 PM - 2:36 PM

   K. Furman, O. Branicka, R. Gawlik, J. Glück
   
   Department and Clinic of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia in Katowice, Poland

4. Sodium benzoate: positive patch test coexisting with positive single-blinded placebo-controlled oral food challenge in the patient with urticaria
   
   2:36 PM - 2:48 PM

   B. Sadowska, M. Gawinowska, M. Sztormowska, M. Chełmińska
   
   Clinic of Allergology, Department of Pneumology and Allergology, Medical University of Gdańsk, Poland

5. Photoallergic contact dermatitis – case report
   
   2:48 PM - 3:00 PM

   K. Waligóra-Dziwak, D. Jenerowicz, Z. Adamski, M. Czarnecka-Operacz
   
   Department and Clinic of Dermatology, Heliodor Święcicki Clinical Hospital of Poznan University of Medical Sciences, Poland

prof. Barbara Rogala (Katowice, Poland), dr Kamil Janeczek (Lublin, Poland)

1. Nasal haemorrhage as a potentially fatal complication of high-flow nasal oxygen therapy – case report
   
   2:00 PM - 2:10 PM

   K. Piwowarek, A. Skibińska, J. Kruszewski, K. Kłos
   
   Clinic of Infectious Diseases and Allergology, Military Institute of Medicine in Warsaw, Poland

2. DNA methylation profile in patients with indolent systemic mastocytosis
   
   2:10 PM - 2:20 PM

   A. Górska, E. Jabłońska, E. Reszka, M. Niedoszytko, M. Lange, M. Gruchała-Niedoszytko, J. Jarczak, D. Strapagiel, M. Górska-Ponikowska, P. Bastian, I. Pelikant-Małecka, B. Nedoszytko
   
   Department of Allergology, Medical University of Gdansk, Poland

3. Efficacy of omalizumab in a patient with chronic spontaneous urticaria and coexisting Crohn’s disease
   
   2:20 PM - 2:30 PM

   I. Kupryś-Lipińska¹, M. Skibińska², A. Janiak³, M. Kołacińska-Flont⁴, K. Molińska¹, J. Molińska¹, J. Narbutt², P. Kuna<sup>1
   
   1</sup> Clinic of Internal Diseases, Asthma and Allergies, Medical University of Lodz, Poland
   ² Clinic of Dermatology, Paediatric Dermatology and Oncology, Medical University of Lodz, Poland
   ³ Clinic of Gastrointestinal Diseases, Medical University of Lodz, Poland
   ⁴ Clinical Department of Internal Diseases, Asthma and Allergies with Paediatric Ward, N. Barlicki University Clinical Hospital No. 1 in Lodz, Poland

4. Efficacy of omalizumab in a patient with chronic spontaneous urticaria and coexisting spontaneous hyperplasia
   
   2:30 PM - 2:40 PM

   I. Kupryś-Lipińska¹, M. Kołacińska-Flont², K. Molińska¹, J. Molińska¹, P. Kuna<sup>1
   
   1</sup> Clinic of Internal Diseases, Asthma and Allergies, Medical University of Lodz, Poland
   ² Clinical Department of Internal Diseases, Asthma and Allergies with Paediatric Ward, N. Barlicki University Clinical Hospital No. 1 in Lodz, Poland

5. Efficacy of omalizumab in the control of stenocardia symptoms accompanying chronic spontaneous urticaria – case report
   
   2:40 PM - 2:50 PM

   I. Kupryś-Lipińska¹, M. Kołacińska-Flont², K. Molińska¹, J. Molińska¹, P. Kuna<sup>1
   
   1</sup> Clinic of Internal Diseases, Asthma and Allergies, Medical University of Lodz, Poland
   ² Clinical Department of Internal Diseases, Asthma and Allergies with Paediatric Ward, N. Barlicki University Clinical Hospital No. 1 in Lodz, Poland

6. Anaphylaxis out in the cold- are epinephrine autoinjectors safe in freezing temperatures?
   
   2:50 PM - 3:00 PM

   P. Łacwik, A. Białas, M. Wielanek, M. Skłodowska, M. Kupczyk, P. Górski, P. Kuna
   
   Jan Kochanowski University in Kielce, Poland; Medical University of Lodz, Poland

prof. Aneta Krogulska (Bydgoszcz, Poland), prof. Marcin Kurowski (Łódź, Poland)

1. Incidence of bronchial asthma and chronic obstructive pulmonary disease (COPD) in patients with COVID-19 and the impact on the evolution of the infection – own experience from the SARS-CoV-2 pandemic
   
   2:00 PM - 2:06 PM

   K. Kłos, K. Piwowarek, J. Kruszewski, A. Chciałowski, K. Plewka, I. Klajnowicz, W. Urbańska, W. Włodarczyk, M. Abramowicz, A. Skibińska
   
   Clinic of Infectious Diseases and Allergology, Military Institute of Medicine in Warsaw, Poland

2. Evaluation of efficacy and durability of clinical improvement in patients with urticaria resistant to standard therapy, treated with omalizumab
   
   2:08 PM - 2:14 PM

   I. Kupryś-Lipińska¹, J. Molińska¹, K. Molińska¹, P. Majak², M. Kołacińska-Flont³, P. Kuna<sup>1
   
   1</sup> Clinic of Internal Diseases, Asthma and Allergies, Medical University of Lodz, Poland
   ² Clinic of Paediatric Pulmonology, Medical University of Lodz, Poland
   ³ Clinical Department of Internal Diseases, Asthma and Allergies with Paediatric Ward, N. Barlicki University Clinical Hospital No. 1 in Lodz, Poland

3. Effect of omalizumab on quality of life in patients with chronic spontaneous urticaria
   
   2:16 PM - 2:22 PM

   J. Molińska¹, K. Molińska¹, P. Majak², M. Kołacińska-Flont³, P. Kuna¹, I. Kupryś-Lipińska<sup>1
   
   1</sup> Clinic of Internal Diseases, Asthma and Allergies, Medical University of Lodz, Poland
   ² Clinic of Paediatric Pulmonology, Medical University of Lodz, Poland
   ³ Clinical Department of Internal Diseases, Asthma and Allergies with Paediatric Ward, N. Barlicki University Clinical Hospital No. 1 in Lodz, Poland

4. Variability of pollen seasons of allergenic plants in Poland in the context of climate change
   
   2:24 PM - 2:30 PM

   D. Myszkowska, A. Kubik-Komar, K. Piotrowicz, K. Dąbrowska-Zapart, Ł. Grewling, I. Kasprzyk, B. Majkowska-Wojciechowska, M. Malkiewicz, K. Piotrowska-Weryszko, M. Puc, E. Czarnobilska
   
   Institute of Clinical and Environmental Allergology, Jagiellonian University Medical College, Kraków, Poland

5. Clinical significance of determinations of plasma PAF acetylhydrolase activity in anaphylaxis
   
   2:32 PM - 2:38 PM

   K. Piwowarek, A. Rzeszotarska, J. Korsak, A. Juszkiewicz, A. Chciałowski, J. Kruszewski
   
   Clinic of Infectious Diseases and Allergology, Military Institute of Medicine in Warsaw, Poland

6. Mas-Related G Protein-Coupled Receptor-X2 serum level in allergic and non-allergic individuals
   
   2:40 PM - 2:48 PM

   G. Porebski², A. Dziadowiec¹, M. Kwitniewski<sup>1
   
   1</sup> Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland
   ² Institute of Clinical and Environmental Allergology, Jagiellonian University Medical College, Kraków, Poland

7. Summary
   
   2:48 PM - 3:00 PM

prof. Michał Panek (Łódź, Poland), prof. Maciej Chałubiński (Łódź, Poland)

1. Evaluation of iNKT lymphocyte subpopulations in children with allergic rhinitis
   
   2:00 PM - 2:06 PM

   K. Janeczek, M. Mikołajczyk, E. Markut-Miotła, W. Kowalska, M. Zarobkiewicz, A. Emeryk
   
   Clinic of Paediatric Pulmonary Diseases and Rheumatology of II Department of Paediatrics, Medical University of Lublin, Poland

2. Costs of the hospital treatment with inhaled glucocorticosteroids in children with asthma depending on the inhalation method
   
   2:08 PM - 2:14 PM

   A. Bodajko-Grochowska¹, K. Janeczek¹, A. Jędrzejewski², I. Czerwińska-Pawluk³, E. Markut-Miotła¹, A. Emeryk<sup>1,2
   
   1</sup> Clinic of Paediatric Pulmonary Diseases and Rheumatology, Medical University of Lublin, Poland
   ² Department and Institute of Paediatric Nursing, Medical University of Lublin, Poland
   ³ Functional Research Laboratory, University Children’s Hospital, Lublin, Poland

3. The impact of the COVID-19 pandemic on admissions to the Emergency Department of the University Clinical Centre in Gdańsk due to sudden allergic conditions
   
   2:16 PM - 2:22 PM

   I. Damps-Konstańska, M. Niedoszytko, E. Jassem
   
   Clinic of Allergology, Medical University of Gdańsk, Poland

4. The effect of human rhinovirus HRV16 on enzyme expression of the arachidonic acid metabolic pathway in human pulmonary vascular endothelium
   
   2:24 PM - 2:30 PM

   K. Klimczak, R. Szewczyk, A. Likońska, M. L Kowalski, M. Chałubiński
   
   Clinic of Immunology and Allergy, Medical University of Lodz, Poland

5. Safety of an accelerated dose escalation scheme for a one strength subcutaneous allergen immunotherapy preparation in patients with allergic rhinitis triggered by house dust mite allergens
   
   2:32 PM - 2:38 PM

   A. Kosowska^1,2, M. Zemelka-Wiącek², E. Popowicz^1,2, J. Zajac^1,2, M. Jutel<sup>1,2
   
   1</sup> ALL-MED Medical Research Institute, Wrocław, Poland
   ² Department of Clinical Immunology, Wrocław Medical University, Wrocław, Poland

6. Analysis of early changes in metabolomic panel in patients receiving ultrarush protocol during bee venom immunotherapy
   
   2:40 PM - 2:48 PM

   M. M. Tomasiak-Łozowska¹, M. Ciborowski², A. Lis¹, M. Klimek¹, M. Czaban¹, W. Izdebska³, D. Wróblewska³, K. Grubczak⁴, J. Gronek³, M. Moniuszko^1,4.
   
   ¹ Clinic of Allergology and Internal Diseases, Medical University of Bialystok, Poland
   ² Clinical Research Centre, Medical University of Bialystok, Poland
   ³ Student Research Circle at the Clinic of Allergology and Internal Diseases, Medical University of Bialystok, Poland
   ⁴ Department of Regenerative Medicine and Immunoregulation, Medical University of Bialystok, Poland

7. Summary
   
   2:48 PM - 3:00 PM

prof. Maciej Kupczyk (Łódź, Poland)

1. What is the treatment of severe asthma after the COVID-19 pandemic
   prof. Maciej Kupczyk (Łódź, Poland)
   3:00 PM - 3:10 PM
2. Learnings from different IL5 targeting in eosinophil biology in severe asthma
   prof. Arnaud Bourdin (France)
   3:10 PM - 3:30 PM
3. The latest reports on the treatment of patients with mepolizumab
   prof. Adam Barczyk (Katowice, Poland)
   3:30 PM - 3:40 PM
4. The case of a patient with severe asthma
   dr Małgorzata Farnik (Katowice, Poland)
   3:40 PM - 3:50 PM
5. Q&A Session
   
   3:50 PM - 4:00 PM

organised within the framework of the research and training grant awarded by GSK

prof. Krzysztof Buczyłko (Łódź, Poland)

1. Differential diagnosis of rhinitis
   prof. Krzysztof Buczyłko (Łódź, Poland)
   3:00 PM - 3:20 PM
2. Exercise induced rhinitis: is it another form of allergic rhinitis?
   prof. Radosław Gawlik (Katowice, Poland)
   3:20 PM - 3:40 PM
3. Surgical treatment of rhinitis
   prof. Dariusz Jurkiewicz (Warszawa, Poland)
   3:40 PM - 4:00 PM
4. Local allergic rhinitis
   dr hab. Edyta Krzych-Fałta (Warszawa, Poland)
   4:00 PM - 4:20 PM
5. Discussion
   
   4:20 PM - 4:30 PM

organised within the framework of the research and training grant awarded by PTA

dr Marcin Stobiecki (Kraków, Poland)

organised within the framework of the research and training grant awarded by CSL Behring

prof. Jacek Szepietowski (Wrocław, Poland)

organised within the framework of the research and training grant awarded by Leo Pharma

Expert:
prof. Jacek Szepietowski (Wrocław, Poland)

PRO: Prof. Andrzej M. Fal
CONTRA: Prof. Bolesław Samoliński

prof. Rafał Pawliczak (Łódź, Poland)

organised within the framework of the research and training grant awarded by Polpharma

dr hab. Edyta Krzych-Fałta (Warszawa, Poland)

1. What has the SARS-Cov-2 pandemic taught us, as seen by an allergist?
   prof. Bolesław Samoliński (Warszawa, Poland)
   5:30 PM - 5:55 PM
2. Allergic diseases (including childhood allergies) and asthma in the COVID era
   prof. Adam Sybilski (Warszawa, Poland)
   5:55 PM - 6:20 PM
3. How SARS-CoV-2 changed Polish nursing
   dr Mariola Łodzińska (Warszawa, Naczelna Izba Pielęgniarek i Położnych)
   6:20 PM - 6:45 PM

organised within the framework of the research and training grant awarded by PTA

prof. Rudolf Valenta (Wiedeń, Austria)

organised within the framework of the research and training grant awarded by HVD

prof. Maciej Kupczyk (Łódź, Poland)

1. New insights into biomarker-guided phenotyping of asthma with implications for disease mechanisms
   prof. Sven-Erik Dahlén (Stockholm, Sweden)
   7:00 PM - 7:30 PM
2. Recent developments in allergology in the light of the latest publications
   prof. Paweł Majak (Łódź, Poland)
   7:30 PM - 8:00 PM

organised within the framework of the research and training grant awarded by LEK-AM

prof. Marita Nittner-Marszalska (Wrocław, Poland), prof. Marek Niedoszytko (Gdańsk, Poland)

1. Personal conditions of anaphylaxis
   prof. Jerzy Kruszewski (Warszawa, Poland)
   7:00 PM - 7:25 PM
2. The comparison of risk factors, clinical symptoms and anaphylaxis treatment of children (age range 0-18 years) in single Polish clinical center and the data of European Anaphylaxis Registry
   dr Izabela Tarczoń (Kraków, Poland)
   7:25 PM - 7:50 PM
3. Mast cel activation syndrom and mastocytosis
   dr Aleksandra Górska (Gdańsk, Poland)
   7:50 PM - 8:15 PM
4. Discussion
   
   8:15 PM - 8:30 PM

organised within the framework of the research and training grant awarded by PTA